GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Wanjia Group Holdings Ltd (HKSE:00401) » Definitions » EV-to-EBIT

Wanjia Group Holdings (HKSE:00401) EV-to-EBIT : 14.26 (As of May. 15, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Wanjia Group Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Wanjia Group Holdings's Enterprise Value is HK$51.8 Mil. Wanjia Group Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$3.6 Mil. Therefore, Wanjia Group Holdings's EV-to-EBIT for today is 14.26.

The historical rank and industry rank for Wanjia Group Holdings's EV-to-EBIT or its related term are showing as below:

HKSE:00401' s EV-to-EBIT Range Over the Past 10 Years
Min: -56.81   Med: -0.7   Max: 281.6
Current: 11.94

During the past 11 years, the highest EV-to-EBIT of Wanjia Group Holdings was 281.60. The lowest was -56.81. And the median was -0.70.

HKSE:00401's EV-to-EBIT is ranked better than
51.85% of 81 companies
in the Medical Distribution industry
Industry Median: 13.3 vs HKSE:00401: 11.94

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Wanjia Group Holdings's Enterprise Value for the quarter that ended in Sep. 2023 was HK$53.8 Mil. Wanjia Group Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$3.6 Mil. Wanjia Group Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 6.75%.


Wanjia Group Holdings EV-to-EBIT Historical Data

The historical data trend for Wanjia Group Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanjia Group Holdings EV-to-EBIT Chart

Wanjia Group Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.86 -11.62 -27.04 -2.14 26.42

Wanjia Group Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.14 - 26.42 -

Competitive Comparison of Wanjia Group Holdings's EV-to-EBIT

For the Medical Distribution subindustry, Wanjia Group Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanjia Group Holdings's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Wanjia Group Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Wanjia Group Holdings's EV-to-EBIT falls into.



Wanjia Group Holdings EV-to-EBIT Calculation

Wanjia Group Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=51.760/3.631
=14.26

Wanjia Group Holdings's current Enterprise Value is HK$51.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wanjia Group Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$3.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanjia Group Holdings  (HKSE:00401) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Wanjia Group Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=3.631/53.79087
=6.75 %

Wanjia Group Holdings's Enterprise Value for the quarter that ended in Sep. 2023 was HK$53.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wanjia Group Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was HK$3.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanjia Group Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Wanjia Group Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanjia Group Holdings (HKSE:00401) Business Description

Traded in Other Exchanges
N/A
Address
25 Canton Road, Harbour City, Suite 1801, 18th Floor, Tower 1, The Gateway, Kowloon, Hong Kong, HKG
Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business.

Wanjia Group Holdings (HKSE:00401) Headlines

No Headlines